Asembia
Asembia is a privately held specialty pharmaceutical services company that provides patient access, distribution strategy, group purchasing, pharmacy network, data insights, and technology solutions to pharmaceutical manufacturers, specialty pharmacies, health systems, and prescribers across the USA.
- Company typePrivate
- Founded2005
- HeadquartersFlorham Park, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Asembia does
Asembia is a privately held specialty pharmaceutical services company founded in 2005 and headquartered in Florham Park, New Jersey, operating as a platform-based ecosystem serving pharmaceutical manufacturers, biotech companies, specialty pharmacies, health systems, prescribers, and payors across the USA. The company pioneered specialty pharmacy as a distinct class of trade and built a leading group purchasing organization (GPO) focused on this segment.
Its core technology is Asembia-1, an integrated web-based software platform that optimizes operations, workflow, and patient management while delivering business intelligence. Around this platform Asembia offers modular products including Prescriber Portals (referral and prescription status visibility), PA Solutions (prior authorization and ePA repository), Manufacturer Dashboard (real-time prescription tracking and reporting), Pharmacy Analytics (clinical and operational performance data), and Pharmacy Finder. ASPN Pharmacies, a wholly owned subsidiary division, obtained Surescripts RxTransfer certification in December 2025 to enable secure electronic prescription transfers.
Asembia's revenue model blends managed services (Patient Access + Connected Care, Distribution Strategy, Pharmacy Network), transaction-based GPO fees (group purchasing discounts, rebates, and incentive programs), and subscription/recurring revenue from technology and Data + Business Insights offerings. The company contracts with 35,000+ pharmacies in the USA, employs over 800 professionals, and operates the AXS annual summit, which at AXS26 drew nearly 10,000 attendees from 1,500+ organizations. Recent strategic moves include a partnership with Outcomes (April 2025) extending reach to 100+ million lives and the launch of the ASPN Digital Retail Network (April 2026).
Asembia firmographics
Firmographics- Name
- Asembia
- Legal name
- Asembia LLC
- Website
- https://asembia.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Asembia is a privately held specialty pharmaceutical services company that provides patient access, distribution strategy, group purchasing, pharmacy network, data insights, and technology solutions to pharmaceutical manufacturers, specialty pharmacies, health systems, and prescribers across the USA.
- Ownership category
- akta.pro rank
Asembia industry classification
Industry- Product category
- Specialty Pharmacy Services
- NAICS
- All Other Miscellaneous Ambulatory Health Care Services (621999)
- SIC
- Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP) (HLACAKAO)
- akta.pro secondary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
Keywords
Where Asembia is headquartered
LocationHeadquarters
- HQ city
- Florham Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Asembia business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Others
Revenue model
- Patient Access + Connected Care Services: Customizable and scalable patient support service model streamlining intake, benefit investigation, prior authorization, and other patient access activities through patient support centers. Includes clinical expertise, compassionate care coordinators, and compliance/adherence programs.
- Group Purchasing Organization (GPO): Negotiates discounts with distributors and vendors, finds rebates, fee-to-service programs, and creates incentive opportunities for pharmaceutical manufacturers, distributors, vendors, and suppliers. Provides product cost savings through longstanding relationships.
- Distribution Strategy Services: Expert advisory services for distribution channel optimization, including identifying redundancies, waste elimination, new growth areas, and cost savings through distribution channels. Tailored network development for partners.
- Pharmacy Network Services: Contracts, aligns, supports, and services products across 35,000+ pharmacies in the USA. Includes network optimization, pharmacy network development, and fulfillment services across retail, specialty, health system, and home delivery channels.
- Data + Business Insights: Multi-channel data intelligence services providing real-time insights across retail, specialty, home delivery, infusion, health systems, long-term care, and payor channels. Includes data analytics, trend monitoring, and actionable insights.
- Technology + Software Solutions: Proprietary technology platforms including Asembia-1, prescriber portals, PA solutions, manufacturer dashboards, and pharmacy analytics sold as integrated software solutions.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels8 records
Asembia product offering
Product offeringCore offering
Asembia provides specialty pharmaceutical services to pharmaceutical manufacturers, biotech companies, pharmacies, and healthcare providers through an integrated ecosystem encompassing Patient Access and Connected Care (HUB services), Distribution Strategy advisory, Group Purchasing Organization services, a 35,000+ pharmacy network, multi-channel Data and Business Insights, and the proprietary Asembia-1 technology platform. The company streamlines specialty medication access, prior authorization, patient adherence, and distribution for complex therapies across the US market.
Product overview
Asembia is a specialty pharmaceutical services company that operates as a platform-based ecosystem. The core technology is the Asembia-1 integrated web-based software platform, which serves as the central hub supporting operations, workflow, patient management, and business intelligence. Around this platform, Asembia offers multiple software modules including Prescriber Portals (streamlined referrals and Rx status visibility), PA Solutions (prior authorization and ePA repository), Manufacturer Dashboard (real-time prescription tracking), Pharmacy Analytics (clinical and operational performance data), and Pharmacy Finder. The company complements its technology with service offerings: Patient Access + Connected Care (patient support and education programs with pharmacy distribution), Distribution Strategy (advisory and execution services), Group Purchasing (GPO with negotiated discounts), Pharmacy Network (35,000+ contracted pharmacies), and Multi-Channel Intelligence/Data Analytics services. Founded in 2005, Asembia pioneered specialty pharmacy as a distinct class of trade and developed the leading GPO for this segment.
Differentiator
Problem solved
Functional benefit
Brands
- Asembia-1: An integrated, web-based software platform that optimizes operations, workflow, and patient management while providing robust business intelligence.
- ASPN Digital Retail Network
Products and services
- Asembia-1
Quantifiable outcome
- Pharmacy professionals view expanding role of pharmacists as leading growth opportunity (77% in XiFin survey)
- +2 more outcomes
Companies that use Asembia
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles3 records
Asembia technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature7 records
Asembia partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- SurescriptscoreASPN Pharmacies, a division of Asembia LLC, obtained Surescripts RxTransfer certification. This certification enhances interoperability, reduces prescription errors, and accelerates care transitions by enabling secure electronic prescription transfers between pharmacies. The certification supports pharmacists and retail pharmacy partners in streamlining prescription management and improving patient access to therapies.
- OutcomescoreStrategic partnership integrating Asembia's HUB services into Outcomes' clinical engagement platform. This collaboration enables proactive patient engagement during the prescription journey, allowing patients to directly reach out to Asembia's patient services team for timely assistance with prescribed therapies. The Outcomes platform connects with over 100 million lives through its network of pharmacies. The partnership aims to reduce prescription abandonment and improve health outcomes.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
Asembia competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Top-3 US pharmaceutical distributor with significant specialty distribution, GPO, and biopharma services — broad incumbent competing across multiple of Asembia's product lines including distribution strategy and data services.
- McKesson: Largest US pharma distributor with US Oncology, Biologics-by-McKesson, and CoverMyMeds prior-authorization platform — competes in specialty distribution, patient access, and PA technology where Asembia also operates.
- Express Scripts / Evernorth (Cigna): Largest US PBM with integrated specialty pharmacy (Accredo) and patient services — competes with Asembia's HUB, distribution strategy, and patient access offerings within the specialty value chain.
- Walgreens Boots Alliance (AllianceRx Walgreens Prime): Large retail pharmacy chain with a significant specialty pharmacy arm (AllianceRx Walgreens Prime) — overlaps with Asembia's pharmacy network and specialty distribution services.
- CVS Health (CVS Specialty / Caremark): Vertically integrated PBM-pharmacy-insurer that operates CVS Specialty and Aetna; both a customer/partner of Asembia at industry summits and a direct competitor across specialty pharmacy, PA, and patient engagement.
- Cencora (formerly AmerisourceBergen): Major US pharma distributor and specialty services provider (via its US Bioservices/Lash Group) — competes across specialty distribution, HUB services, and patient access where Asembia operates.
Direct peers
- Eversana: Eversana is a privately-held life sciences commercialization services provider offering patient services, distribution, GPO-style support, and data/analytics to pharma manufacturers — closely mirroring Asembia's integrated service stack for specialty pharma.
- Shields Health Solutions: Specialty pharmacy provider embedded in health systems, partnering with Asembia (per Asembia customer data) on pharmacist-led specialty care models that improve outcomes — comparable specialty-pharmacy-network + patient-services orientation.
- PANTHERx Rare Pharmacy: Specialty and rare-disease pharmacy with strong manufacturer and patient support services focus; competes with Asembia's pharmacy network and patient access services in the high-touch specialty and rare disease segments.
- Precision Medicine Group: Specialty pharma services firm providing commercialization, market access, patient services, and data analytics to biopharma — overlaps with Asembia's Patient Access, Distribution Strategy, and Data + Business Insights offerings.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat7 records
Key risks5 records
Key highlights7 records
Customer concentration
Asembia social profiles
Digital presenceAsembia compliance and trust
Trust signalCompliance2 records
Asembia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Asembia leadership team
Management profileNumber of profiles
Profiles3 records
Asembia subsidiaries and ownership
Company hierarchySubsidiaries1 record
Asembia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Asembia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Asembia
What does Asembia do?
Asembia provides specialty pharmaceutical services to pharmaceutical manufacturers, biotech companies, pharmacies, and healthcare providers through an integrated ecosystem encompassing Patient Access and Connected Care (HUB services), Distribution Strategy advisory, Group Purchasing Organization services, a 35,000+ pharmacy network, multi-channel Data and Business Insights, and the proprietary Asembia-1 technology platform. The company streamlines specialty medication access, prior authorization, patient adherence, and distribution for complex therapies across the US market.
Is Asembia a public or private company?
Asembia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Asembia founded?
Asembia was founded in 2005. It employs 501 to 1,000 people.
Where is Asembia based?
Asembia is headquartered in Florham Park, United States, in the North America region.
How does Asembia make money?
Six revenue lines are on record. Patient Access + Connected Care Services are the primary driver. The others are group Purchasing Organization (GPO), distribution Strategy Services, pharmacy Network Services, data + Business Insights and technology + Software Solutions.
Who are Asembia's main competitors?
Broad incumbents on record are Cardinal Health, McKesson, Express Scripts / Evernorth (Cigna), Walgreens Boots Alliance (AllianceRx Walgreens Prime), CVS Health (CVS Specialty / Caremark) and Cencora (formerly AmerisourceBergen). Direct peers are Eversana, Shields Health Solutions, PANTHERx Rare Pharmacy and Precision Medicine Group.
Does Asembia have an API?
No public API is recorded for Asembia.
What industry is Asembia in?
Asembia's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLACAKAO, Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP), with a secondary code of HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant). Its NAICS code is 621999 and its SIC code is 8090.